针对加拿大的淋巴结膜炎药物获取的专注司法扫描:计划报告
Rohini Naipaul1, Catherine Marques1, Jenny Ng2
1Ontario Health (Ontario Renal Network), Toronto, Canada.
Canadian journal of kidney health and disease
|August 15, 2023
概括
对于罕见的脏疾病,如质核炎 (GN) 的免疫抑制药物的获取在加拿大各省不同. 一项审查发现,虽然有许多药物可用,但不一致的公共资金标准和流程为患者和临床医生创造了接入差距.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药物经济学 药物经济学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 加拿大的淋巴细胞炎 (GN) 管理越来越依赖于昂贵的免疫抑制剂 (IS).
- 利益相关方的反表明,及时和全面获得这些NG药物存在挑战.
- 安大略脏网络 (ORN) 旨在改善获得GN治疗的机会.
研究的目的:
- 检查临床医生在加拿大各省获得GN药物的经验.
- 分析公共药物覆盖标准和时间表,以选择在成年GN中使用的IS药物.
- 为改善药物获取的ORN倡议提供信息.
主要方法:
- 2018年对7个加拿大省份进行了司法扫描,于2022年7月更新.
- 从灰色文献,在线来源,省级药物计划和临床专家中收集了信息.
- 专注于公共资金政策和获得关键IS药物的资格 (塔克罗利木斯,环素,货币货币基金等). ) 的情况.
主要成果:
- 在各省份中,GN的处方模式是相似的,但公共药物资助政策有所不同.
- 大多数省份对IS代理商使用个案审查,导致可变的资助标准和时间表.
- 不列颠哥伦比亚省提供了一个更加综合和高效的系统,GN特定的药物表格.
结论:
- 由于省际差异,加拿大各地的公共资助的GN药物仍然存在差距.
- 药物供应,资金标准和申请流程的差异会影响公平获取.
- 一个泛加拿大资金方法可能是必要的,以解决罕见病药物获取的差异.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
01:17Factors Affecting Renal Clearance: Renal Impairment
119
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:15Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
01:06Renal Drug Clearance: Overview
248
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
248